AvKARE

Pulaski, United States Founded: 2007 • Age: 19 yrs Acquired By Amneal
Pharmaceuticals and infection control products are distributed by AvKARE.

About AvKARE

AvKARE is a Healthcare company based in Pulaski (United States) founded in 2007, and was acquired by Amneal in December 2019. Pharmaceuticals and infection control products are distributed by AvKARE. The company has 108 employees. Its focus areas include Pharmaceutical Distributors and Diversified. Its legal entity is AVKARE, INC. Its competitors include AmerisourceBergen, Renee and Apothkary; 2 of its 3 listed competitors have raised funding.

Company details

AvKARE was founded in 2007 and is headquartered in Pulaski, United States. Operations are centered on the distribution of pharmaceuticals and infection control products within the healthcare sector. A variety of generic drugs and related supplies are provided to pharmacies, hospitals, and other facilities across the country. The companys domain, avkare.com, supports these distribution activities, ensuring compliance with industry standards.

  • Headquarters Pulaski, United States
  • Employees 108
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website avkare.com
  • Social LinkedIn X Facebook
  • Acquired by Amneal (Dec 2019)
  • Legal Name Avkare, Inc.
Key Metrics
  • Latest Funding Round
    $210M (USD), Debt – Conventional

    Jan 2020

  • Investors
  • Employee Count
    108
  • Acquired by
    Amneal

    (Dec 2019)

Funding Insights of AvKARE

  • Total Rounds 1
  • Last Round Debt – Conventional β€” $210M
  • First Round $210M

    (Jan 2020)

All 1 funding rounds of AvKARE with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2020$210MDebt – Conventional––
–
Valuation history

1 investors in total: 1 institutional.

Investors in AvKARE

AvKARE has secured backing from 1 investor. Prominent investors backing the company include Amneal.

All
InvestorDescriptionFounded YearDomainLocation
Manufacturer of generics formulations
2002amneal.comBridgewater, United States
Premium access

Investor details for AvKARE

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of AvKARE

6 people are tracked at AvKARE (3 in leadership, 3 in team); the tracked headcount is 108.

NameRoleGroup
Troy Mizell
President & CeoLeadership
Matt Locke
CTOLeadership
Kerry Dilley
Executive Vice PresidentLeadership
Marcus Manno
Senior Solutions ArchitectTeam
Rick D.
EVP Operations And TechnologyTeam
Kaitlin Lessieu
EVP Of Strategic Initiatives & ExecutionTeam
Premium access

Complete people profiles for AvKARE

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of AvKARE

3 dated milestones of AvKARE across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded AvKARE is founded.
  2. Exit Acquired by Amneal.
  3. Funding First funding round of $210.0M.

Competitors of AvKARE

AvKARE has 3 listed competitors in our database, 2 of them funded. They include AmerisourceBergen, Renee and Apothkary.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
amerisourcebergen.com1985Chesterbrook, United States46,000
Pharmaceutical distribution and supply chain services are provided globally.
renee.com2021Los Angeles, United States$8.2M
Diversified drugs are distributed by Renee in the United States.
apothekary.co2018Falls Church, United States$11.2M
Provides herbal formulas for stress relief, energy, mood, and wellness support.
Premium access

Detailed competitors of AvKARE

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of AvKARE

The website of AvKARE (avkare.com) receives about 4.6K visits a month.

  • Monthly visits
    4.6K

    ▼ 15.8% vs previous month

Similar websites

Websites whose visitors overlap most with AvKARE. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
bioject.com
100%
View details
fda.report
fda.report
97%
#460,872–
freestyleprovider.abbott
freestyleprovider.abbott
58%
#675,516–

Top companies in Pharmaceuticals & Distribution

3 companies that operate in the same segment as AvKARE (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United StatesUSD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United StatesUSD 5.33 B55,000
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Avkare

Premium access

Complete news archive for AvKARE

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about AvKARE

AvKARE was founded in 2007 and raised its 1st funding round 13 years after it was founded.

AvKARE is headquartered in Pulaski, United States.

AvKARE has 108 employees.

AvKARE was founded in 2007 and is headquartered in Pulaski, United States. Operations are centered on the distribution of pharmaceuticals and infection control products within the healthcare sector. A variety of generic drugs and related supplies are provided to pharmacies, hospitals, and other facilities across the country. The companys domain, avkare.com, supports these distribution activities, ensuring compliance with industry standards.

AvKARE's top competitors include AmerisourceBergen, Renee and Apothkary.

AvKARE has 1 investor. Key investors include Amneal.

AvKARE operates through Avkare, Inc..

Yes. AvKARE was acquired by Amneal in December 2019.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available